Witnesses The Rt Hon the Lord Henley, Parliamentary Under-Secretary of State, Department for Business, Energy and Industrial Strategy (BEIS) and the Lord O'Shaughnessy, Parliamentary Under-Secretary of State, Department of Health and Social Care
Witnesses John Bassett, Policy and Scientific Development Director, Institute of Food Science and Technology, Professor Paul Kellam, Chair-Elect of the Policy Committee, Microbiology Society and Dr Mark Downs CSci FRSB, Chief Executive, Royal Society of Biology
Witnesses Professor Sir John Bell, Regius Professor of Medicine, University of Oxford and Chair, Office for Strategic Coordination of Health Research (OSCHR)
Witnesses Dr Michael Hopkins, Senior Lecturer, Science Policy Research Unit, Sussex University and Professor Andy Westwood, Member, Industrial Strategy Commission, and Professor of Government Practice and Vice Dean of Humanities, University of Manchester
Witnesses Dr Ruth McKernan CBE, Chief Executive Officer, Innovate UK, Chris Molloy, Chief Executive Officer, Medicines Discovery Catapult, Keith Thompson, Chief Executive Officer, Cell and Gene Therapy Catapult and Professor Graham Hillier, Strategy and Futures Director, Centre for Process Innovation, High Value Manufacturing Catapult
Witnesses Dr Mark Hammond, Co-founder, Deep Science Ventures, Dr John Bowler, Fund Manager and Global Sector Specialist with responsibility for the health care sector, Schroders PLC, Dr Peter Hughes, Healthcare Equity Analyst, AXA Framlington Biotech Fund and Dr Andrew Elder, Partner, Albion Capital
Witnesses Erik Nordkamp, Chair, American Pharmaceutical Group, and UK Managing Director, Pfizer, Mark Hicken, Vice Chair, American Pharmaceutical Group, and UK Managing Director, Janssen and Louise Houson, UK Managing Director, MSD
Witnesses Dr Glenn Crocker MBE, Representative of the UK Science Park Association (UKSPA) and Chief Executive of BioCity Nottingham Ltd, Dr Iain Thomas, Head of Life Sciences, Cambridge Enterprise and Dr Sally Ann Forsyth, Chief Executive Officer, Norwich Research Park
Witnesses Professor Chris Whitty, Chief Scientific Adviser, Department of Health, Interim Government Chief Scientific Adviser and Interim Head of Government Science and Engineering Profession and Professor Dame Sally Davies, Chief Medical Officer for England, Department of Health
Witnesses Professor Jonathan Elliot, Vice-Principal, Research and Innovation, Royal Veterinary College, Dr David Hughes, Head of Global R&D Technology Scouting, Syngenta and Professor Angela Karp, Director for Science Innovation, Engagement and Partnerships, Rothamsted Research
Witnesses Ian Dodge, National Director for Strategy and Innovation, NHS England, Professor Keith McNeil, Chief Clinical Information Officer Health and Social Care, NHS England and Professor Mike Hannay, Managing Director of the East Midlands Academic Health Science Network (AHSN), NHS England
Witnesses Dr Veronique Birault, Head of Translation, Francis Crick Institute, Dr Simon Boulton, Senior Group Leader, Francis Crick Institute, Dr Kathy Niakan, Group Leader, Francis Crick Institute, Dr Caetano Reis e Sousa, Senior Group Leader, Francis Crick Institute and Professor Charles Swanton, Senior Group Leader, Francis Crick Institute
Witnesses Professor Sir Robert Lechler, President, Academy of Medical Sciences, Professor Joyce Tait, Director of the Innogen Institute at the University of Edinburgh, Royal Society of Edinburgh and Professor Mark Tooley, President of the Institute of Physics and Engineering in Medicine, Royal Academy of Engineering
Witnesses Mike Thompson, Chief Executive Officer, Association of the British Pharmaceutical Industry, Nisha Tailor, Head of Policy and Public Affairs, Association of Medical Research Charities and Steve Bates OBE, Chief Executive Officer, BioIndustry Association